Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD. Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD. conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD. Clinical research trials and Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD. medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.. Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD. Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD. clinical trial. Participants oftentimes recieve the finest healthcare available for their Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD. condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "P" Clinical Trials Conditions > Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.

Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.



Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.

For Condition: Macular Degeneration
Status: No longer recruiting
Sponsor(s): Alcon Research ,
Synopsis: The purpose of this study is to demonstrate that Anecortave Acetate is as effective after twelve months of treatment as photodynamic therapy (PDT) with Visudyne in patients eligible for initial PDT treatment for wet age-related macular degeneration.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 50 Years/
Genders: Both
Protocol Entry Criteria: Patients of any race, either gender, aged 50 years and above, diagnosed with subfoveal CNV due to AMD with best corrected logMAR visual acuity of 20/40 (snellen equivalent) to 20/400 (Snellen equivalent) in the study eye. Clinically relevant concomitant diseases will be excluded.
Total Enrollment: 

Location and Contact Information:

US, Canada, Australia and Europe
Ft. Worth,  Texas, 
United States
 


Additional Information:
Study ID Numbers:
  C-01-99; 
Study Start Date: 
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00041483

Other Macular Degeneration Studies:
1. Screening for Studies on Retinovascular Diseases

2. Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.

3. Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)

4. Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)

5. Genetic Factors in Age-Related Macular Degeneration

Related Studies:

Other Macular Degeneration Clinical Trials
Other Texas Clinical Trials
Other Ft. Worth Clinical Trials

Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.

Modify your Search

  Other Macular Degeneration Clinical Trials
  Other Texas Clinical Trials
  Other Ft. Worth Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103